Wellbutrin is not a benzodiazepine. It is an antidepressant that belongs to the aminoketone class, a completely different type of medication from benzodiazepines like Xanax (alprazolam), Valium (diazepam), or Ativan (lorazepam). The two drugs work on different brain chemicals, treat different conditions, and carry very different risk profiles.
How Wellbutrin and Benzos Differ
The confusion likely comes from the fact that both medications are prescribed for conditions involving mood and anxiety. But that’s where the similarities end. Wellbutrin (bupropion) is a weak blocker of norepinephrine and dopamine reabsorption in the brain, two chemicals linked to energy, motivation, and focus. Benzodiazepines work on an entirely different system: they enhance the effect of GABA, the brain’s main calming chemical, which is why they produce sedation and muscle relaxation quickly.
This difference in brain chemistry explains why the two drugs feel so different. Wellbutrin tends to be activating. It can cause restlessness, trouble sleeping, and increased energy, especially early in treatment. Benzodiazepines do the opposite: they slow things down, causing drowsiness, relaxed muscles, and sometimes mental fogginess or poor coordination.
What Wellbutrin Is Approved to Treat
Wellbutrin has three FDA-approved uses: major depression, seasonal affective disorder, and smoking cessation (marketed under the brand name Zyban for that purpose). It is not approved as an anti-anxiety medication, though a 2023 study using propensity-matched groups found that bupropion reduced anxiety symptoms just as effectively as SSRIs over 12 weeks in people with depression. The common clinical concern that Wellbutrin worsens anxiety appears to be unfounded based on that data.
Benzodiazepines, by contrast, are primarily prescribed for anxiety disorders, panic attacks, seizures, and short-term insomnia. They work fast, often within 30 minutes, but are intended for short-term use because of their dependence potential.
Controlled Substance Status
Benzodiazepines are Schedule IV controlled substances under the DEA, meaning they have a recognized potential for abuse and physical dependence. Common examples on the DEA’s controlled substances list include alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and temazepam (Restoril).
Wellbutrin does not appear on the DEA’s controlled substances list at all. It is not considered a drug of abuse in the same category, and prescriptions for it do not carry the same legal restrictions. You can typically get refills without a new prescription each time, unlike many controlled medications.
Withdrawal and Dependence Risks
This is one of the most important practical differences between the two. Stopping benzodiazepines abruptly after regular use can be dangerous and, in severe cases, life-threatening. Withdrawal symptoms typically develop 2 to 10 days after stopping and can last weeks or even months. They include agitation, insomnia, anxiety, panic attacks, tremor, and seizures. The severity depends on how long someone has been taking the drug, the dose, and how quickly they stop. Benzodiazepine withdrawal seizures are one of the leading causes of drug-related seizures seen in emergency departments.
Wellbutrin does not produce the same kind of physical dependence. While any antidepressant can cause discontinuation symptoms if stopped abruptly (mild irritability, mood changes), the process is not associated with the dangerous autonomic instability or seizure risk that characterizes benzodiazepine withdrawal.
Seizure Risk With Wellbutrin
One area where Wellbutrin does carry a notable risk is seizures, but the mechanism is entirely different from benzodiazepine withdrawal seizures. Bupropion lowers the seizure threshold in a dose-dependent way, meaning higher doses increase the risk. In one emergency department study, bupropion was the third leading cause of drug-related seizures (after cocaine intoxication and benzodiazepine withdrawal), and all of the bupropion-related seizures occurred in patients taking 450 mg per day or less, which is within the standard dosing range.
This is why Wellbutrin is contraindicated in people with seizure disorders, eating disorders (which can alter electrolyte balance and lower seizure threshold), or those abruptly discontinuing alcohol or benzodiazepines. If you’re currently taking a benzodiazepine and considering switching to Wellbutrin, the transition needs to be managed carefully because stopping a benzo suddenly while starting Wellbutrin compounds seizure risk from two directions.
Why People Confuse the Two
Part of the confusion stems from the fact that both drugs are sometimes discussed in the context of anxiety treatment. A person prescribed Wellbutrin for depression might wonder whether it’s “the same kind of thing” as the Xanax a friend takes for anxiety. They’re not. They belong to completely different drug classes, affect different neurotransmitter systems, have different side effect profiles, and carry different levels of regulatory control. Wellbutrin is closer in function to other antidepressants than it is to any benzodiazepine, though it’s chemically distinct from SSRIs and older antidepressants as well.